Nautilus Biotechnology, Inc
Fundamentals
Oldest to newest| Line | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Net income | −$50.3M | −$57.9M | −$63.7M | −$70.8M | −$59.0M |
| Operating cash flow | −$39.2M | −$45.8M | −$51.7M | −$59.1M | −$50.7M |
| Free cash flow | −$41.5M | −$48.1M | −$54.2M | −$61.3M | −$52.0M |
| Cash | $185.6M | $114.5M | $19.4M | $27.6M | $12.4M |
| Shares outstanding | 124.3M | 124.9M | 125.1M | 126.1M | 126.5M |